Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Unlike Saccharomyces cerevisiae
RNA polymerase III
, human
RNA polymerase III
has not been entirely characterized. Orthologues of the yeast
RNA polymerase III
subunits C128 and C37 remain unidentified, and for many of the other subunits, the available information is limited to database sequences with various degrees of similarity to the yeast subunits. We have purified an
RNA polymerase III
complex and identified its components. We found that two
RNA polymerase III
subunits, referred to as
RPC8
and RPC9, displayed sequence similarity to the
RNA polymerase II
RPB7 and RPB4 subunits, respectively.
RPC8
and RPC9 associated with each other, paralleling the association of the
RNA polymerase II
subunits, and were thus paralogues of RPB7 and RPB4. Furthermore, the complex contained a prominent 80-kDa polypeptide, which we called RPC5 and which corresponded to the human orthologue of the yeast C37 subunit despite limited sequence similarity. RPC5 associated with RPC53, the human orthologue of S. cerevisiae C53, paralleling the association of the S. cerevisiae C37 and C53 subunits, and was required for transcription from the type 2 VAI and type 3 human U6 promoters. Our results provide a characterization of human
RNA polymerase III
and show that the RPC5 subunit is essential for transcription.
...
PMID:Characterization of human RNA polymerase III identifies orthologues for Saccharomyces cerevisiae RNA polymerase III subunits. 1239 Nov 70